Cat.#: ACPP-1335
| Despition | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1185 | Mouse FGF 1 Protein (AC1185) | 10 µg | inquiry |
| ACPP-1768 | Human SNAP25 Protein (AC1768) | 5 µg | inquiry |
| ACPP-1198 | PDE6 Alpha Blocking Peptide (AC1198) | 250 µg | inquiry |
| ACPP-1773 | Human LIN28 Protein (AC1773) | 2 µg | inquiry |
| ACPP-1696 | Human GHRL Protein (AC1696) | 5 µg | inquiry |
| ACPP-1605 | Human PNMT Protein (AC1605) | 5 µg | inquiry |
| ACPP-1659 | Human Visfatin Protein (AC1659) | 5 µg | inquiry |
| ACPP-1023 | Synthetic Nanodisc Human KCNK9 Protein (AC1023) | 10 µg | inquiry |
| ACPP-1011 | Recombinant Human FGF1 Protein (AC1011) | 50 µg | inquiry |
| ACPP-1066 | Recombinant Human FGF2 Protein (Fc Tag) (AC1066) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.